Mixed Effect Modeling of Sumatriptan Pharmacokinetics During Drug Development. I: Interspecies Allometric Scaling
- 1 January 1997
- journal article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 25 (2) , 149-167
- https://doi.org/10.1023/a:1025728028890
Abstract
Allometric scaling is an empirical examination of the relationships between the pharmacokinetic parameters and size (usually body weight), but it can also involve brain weight for metabolized drug....Keywords
This publication has 21 references indexed in Scilit:
- A new extrapolation method from animals to man: Application to a metabolized compound, mofaroteneLife Sciences, 1995
- Interspecies Scaling of Tebufelone Pharmacokinetic Data and Application to Preclinical ToxicologyPharmaceutical Research, 1995
- Disposition of sumatriptan in laboratory animals and humans.1993
- Preclinical Studies on the Anti-Migraine Drug, SumatriptanEuropean Neurology, 1991
- Interspecies scaling and comparisons in drug development and toxicokineticsXenobiotica, 1990
- Pharmacokinetic Scale-up: Accurate Prediction of Human Pharmacokinetic Profiles from Animal DataJournal of Pharmaceutical Sciences, 1985
- Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative ParadigmDrug Metabolism Reviews, 1984
- Interspecies pharmacokinetic scaling and the Dedrick plotsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1983
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoinJournal of Pharmacokinetics and Biopharmaceutics, 1980